Monday , October 23 2017
Home / Resources / Articles / Abbott Announces Approval of Its New Unique Continuous Glucose Monitor

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor

FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes, eliminates finger sticks….

Abbott has announced that it has received CE Mark for its FreeStyle® Libre Flash Glucose Monitoring System. The system eliminates the need for routine finger pricks, reading glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. In addition, no finger prick calibration is needed — a key differentiator from current continuous glucose monitoring systems. The system will be available in seven countries across Europe in the coming weeks.

Abbott’s FreeStyle Libre System consists of a small, round sensor — approximately the size of a two Euro coins — worn on the back of the upper arm, which measures glucose every minute in interstitial fluid through a small (5mm long, 0.4mm wide) filament that is inserted just under the skin and held in place with a small adhesive pad. A reader is scanned over the sensor to get a glucose result painlessly in less than one second. Scanning can take place while the sensor is under clothing, making testing more discreet and convenient. Each scan displays a real-time glucose result, a historical trend and the direction the glucose is heading. The reader holds up to 90 days of data, providing a historical snapshot of glucose levels over time.

Key features of Abbott’s FreeStyle Libre System include:

  • No finger prick calibration
  • Disposable, water-resistant sensor can be worn on the back of the upper arm for up to 14 days
  • Glucose readings can be taken as many times per day as needed or desired, with a painless one second scan
  • Each scan provides a current glucose reading, 8-hour history and the direction glucose is heading

The data generated by the system is designed to provide actionable trends and patterns that may help people determine how to modify food and other behaviors to better manage their diabetes in consultation with their healthcare professionals

In addition, no finger prick calibration is needed — a key differentiator from current continuous glucose monitoring systems

A recent study conducted by Abbott has shown that the FreeStyle Libre System is clinically proven to be accurate, stable and consistent over 14 days without the need for finger prick calibration. More details on this study will be made available during the Abbott Symposium at the European Association for the Study of Diabetes (EASD) medical conference September 15.

The FreeStyle Libre System will be available in France, Germany, Italy, Netherlands, Spain, Sweden and United Kingdom in the coming weeks and will be available for purchase online through a website in each market.

Practice Pearls:
  • FreeStyle Libre System is clinically proven to be accurate, stable and consistent over 14 days.
  • Finger sticks no longer required.
  • Not yet available in the U.S.

Abbott News Release, Sept 3, 2014